Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy
Open Access
- 10 February 2013
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 45 (4) , 330-338
Abstract
Role of the transforming growth factor-β1 (TGF-β1) gene polymorphisms located at codons 10 and 25 in the genetic predisposition to type 2 diabetes (T2D) and in diabetic nephropathy (DN) in Egyptian patients was investigated. A case control study was done for 99 unrelated Egyptian patients with T2D (50 DN− and 49 DN+) and 98 age- and sex-matched healthy controls. TGF-β1 T869C (codon 10) and G915C (codon 25) polymorphism detection was done by amplification refractory mutation system method. DN+ patients were younger, with higher body mass index, serum triglycerides, serum creatinine, and lower serum albumin than those in DN− patients. Moderate and bad grades of diabetic control were associated with DN (P < 0.001). The TGF-β1 (T869C) C allele, TC and TC + CC genotypes were significantly higher in patients; the T allele and TT genotype were significantly higher in controls (Pc < 0.001). The TGF-β1 TC genotype was associated with DN (Pc < 0.05). Non-significant differences were detected between T2D patients and controls in the frequencies of TGF-β1 (G915C) alleles and genotypes. In conclusion, these preliminary data showed that the TGF-β1 codon 10 C allele, and C allele-containing genotypes may be susceptible, and T allele/TT genotype may be protective factors for T2D and DN+ complications.Keywords
This publication has 45 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Common Variants of Inflammatory Cytokine Genes Are Associated with Risk of Nephropathy in Type 2 Diabetes among Asian IndiansPLOS ONE, 2009
- Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 DiabetesDiabetes Care, 2009
- From Fibrosis to SclerosisDiabetes, 2008
- Elevated serum level and gene polymorphisms of TGF‐β1 in gastric cancerJournal of Clinical Laboratory Analysis, 2008
- ‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulationImmunological Reviews, 2007
- Transforming Growth Factor-β Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 SignalingJournal of Biological Chemistry, 2005
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000